WuXi Biologics (Cayman) Inc. (HKG:2269)
Hong Kong
· Delayed Price · Currency is HKD 33.94
+0.24 (0.71%)
Apr 29, 2026, 4:08 PM HKT
WuXi Biologics Ratios and Metrics
Market cap in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 139,444 | 129,960 | 72,100 | 124,993 | 252,882 | 390,943 | Upgrade
|
| Market Cap Growth | 36.92% | 80.25% | -42.32% | -50.57% | -35.32% | -6.90% | Upgrade
|
| Enterprise Value | 131,834 | 126,322 | 71,052 | 122,776 | 247,673 | 380,146 | Upgrade
|
| Last Close Price | 33.70 | 31.44 | 17.56 | 29.60 | 59.85 | 92.55 | Upgrade
|
| PE Ratio | 26.09 | 23.79 | 20.19 | 33.37 | 50.61 | 93.99 | Upgrade
|
| Forward PE | 20.48 | 21.64 | 17.09 | 22.71 | 37.41 | 77.91 | Upgrade
|
| PS Ratio | 5.75 | 5.36 | 3.63 | 6.66 | 14.65 | 30.95 | Upgrade
|
| PB Ratio | 2.36 | 2.20 | 1.49 | 2.58 | 6.18 | 9.74 | Upgrade
|
| P/TBV Ratio | 2.77 | 2.58 | 1.70 | 2.96 | 6.79 | 10.56 | Upgrade
|
| P/FCF Ratio | - | - | 52.62 | 182.37 | - | - | Upgrade
|
| P/OCF Ratio | - | - | 12.99 | 24.31 | 40.37 | 92.82 | Upgrade
|
| PEG Ratio | 1.28 | 1.13 | 1.99 | 1.39 | 1.02 | 1.99 | Upgrade
|
| EV/Sales Ratio | 5.44 | 5.21 | 3.58 | 6.54 | 14.35 | 30.10 | Upgrade
|
| EV/EBITDA Ratio | 14.98 | 14.35 | 11.42 | 22.61 | 43.22 | 85.50 | Upgrade
|
| EV/EBIT Ratio | 17.82 | 17.08 | 14.56 | 28.34 | 50.36 | 97.69 | Upgrade
|
| EV/FCF Ratio | - | - | 51.85 | 179.13 | - | - | Upgrade
|
| Debt / Equity Ratio | 0.06 | 0.06 | 0.11 | 0.10 | 0.12 | 0.13 | Upgrade
|
| Debt / EBITDA Ratio | 0.39 | 0.39 | 0.82 | 0.89 | 0.86 | 1.18 | Upgrade
|
| Debt / FCF Ratio | - | - | 3.84 | 7.33 | - | - | Upgrade
|
| Net Debt / Equity Ratio | -0.24 | -0.24 | -0.13 | -0.15 | -0.12 | -0.21 | Upgrade
|
| Net Debt / EBITDA Ratio | -1.60 | -1.60 | -0.99 | -1.36 | -0.85 | -1.89 | Upgrade
|
| Net Debt / FCF Ratio | - | - | -4.48 | -10.74 | 13.14 | 2.22 | Upgrade
|
| Asset Turnover | 0.36 | 0.36 | 0.33 | 0.32 | 0.33 | 0.28 | Upgrade
|
| Inventory Turnover | 8.11 | 8.11 | 6.71 | 5.04 | 4.31 | 3.94 | Upgrade
|
| Quick Ratio | 2.97 | 2.97 | 1.98 | 2.35 | 1.56 | 1.85 | Upgrade
|
| Current Ratio | 3.39 | 3.39 | 2.73 | 2.78 | 1.98 | 2.37 | Upgrade
|
| Return on Equity (ROE) | 11.64% | 11.64% | 8.82% | 8.90% | 13.20% | 13.09% | Upgrade
|
| Return on Assets (ROA) | 6.88% | 6.88% | 5.05% | 4.63% | 5.81% | 5.43% | Upgrade
|
| Return on Invested Capital (ROIC) | 12.99% | 13.11% | 9.71% | 9.72% | 12.78% | 13.38% | Upgrade
|
| Return on Capital Employed (ROCE) | 12.00% | 12.00% | 9.50% | 8.00% | 10.80% | 8.90% | Upgrade
|
| Earnings Yield | 3.92% | 4.20% | 4.95% | 3.00% | 1.98% | 1.06% | Upgrade
|
| FCF Yield | - | - | 1.90% | 0.55% | -0.15% | -0.97% | Upgrade
|
| Buyback Yield / Dilution | 1.22% | 1.22% | 2.80% | 0.62% | 1.04% | -5.05% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.